# A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors

> **NCT06632574** · PHASE1 · RECRUITING · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** paclitaxel cationic liposomes

## Key facts

- **NCT ID:** NCT06632574
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-03-19
- **Primary completion:** 2025-10-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06632574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06632574, "A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06632574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*